Abstract
3579Background: TAS-102 is an oral combination of trifluridine (FTD) and tipiracil hydrochloride. Incorporation of tri-phosphorylated FTD into DNA is the main anti-tumor mechanism of action. We hyp...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
